COFETUZUMAB
UNII POD4A619N7

Substance Identification & Data

This profile provides standardized clinical and technical data for Cofetuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) POD4A619N7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1869928-62-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
POD4A619N7
CAS Registry Number
1869928-62-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
COFETUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C174847
National Cancer Institute reference terminology for clinical and research data.
INN ID
10675
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
DE-151
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cofetuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

COFETUZUMAB

Common Names & Synonyms

COFETUZUMAB [INN]
COFETUZUMAB [USAN]
IMMUNOGLOBULIN G1, ANTI-(HUMAN PROTEIN TYROSINE KINASE 7) (HUMANIZED MUS MUSCULUS CLONE HU24 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MUS MUSCULUS CLONE HU24 .KAPPA.-CHAIN, DIMER

Technical Codes

PF-06523435

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus